Study identification

PURI

https://redirect.ema.europa.eu/resource/44414

EU PAS number

EUPAS24224

Study ID

44414

Official title and acronym

PATTERN OF USE AND SAFETY PROFILE OF BRANDED VS GENERIC ANTIEPILEPTIC DRUGS

DARWIN EU® study

No

Study countries

Italy

Study status

Finalised
Research institution and networks

Institutions

Contact details

Ersilia Lucenteforte

Primary lead investigator
Study timelines

Date when funding contract was signed

Planned:
Actual:

Study start date

Planned:
Actual:

Data analysis start date

Planned:

Date of final study report

Planned:
Actual:
Sources of funding
Other

More details on funding

University of Florence
Study protocol
Initial protocol
English (439.31 KB - PDF)View document
Regulatory

Was the study required by a regulatory body?

No

Is the study required by a Risk Management Plan (RMP)?

Not applicable